Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Genital Herpes Treatment Market to reach USD XX billion by 2027.

Global Genital Herpes Treatment Market Size study, by Drug Type (Acyclovir, Valacyclovir, Famciclovir) Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) Route of Administration (Oral, Topical, Injectable) Indication (HSV-1, HSV-2) and Regional Forecasts 2021-2027

Product Code: HLSDT-33685385
Publish Date: 17-07-2021
Page: 200

Global Genital Herpes Treatment Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Herpes simplex virus (HSV) causes genital herpes, a sexually transmitted illness that is spread by infected people’s sperm, saliva, and vaginal fluids. Herpes simplex viruses come in two varieties: HSV-1 and HSV-2. Blisters on the genital organs, blisters in the mouth, lips, and other regions, itching or tingling in the infected areas, pelvic discomfort, vaginal discharge, and other symptoms are all frequent genital herpes symptoms. Therapy options for genital herpes include medication, episodic treatment, and suppressive treatment, among others. Commercially available antiviral medications for the treatment of genital herpes include Acyclovir, Famciclovir, and Valacyclovir. Over the projected period, the rising frequency of sexually transmitted diseases, particularly genital herpes, is likely to drive demand for genital herpes therapy. According to the Centers for Disease Control and Prevention, genital herpes affects roughly 50 million people in the United States. During the projected period, factors such as rising genital herpes diagnosis rates in emerging nations and expanding clinical trials of genital herpes vaccines have further fueled the expansion of the genital herpes market. Sanofi Pasteur, for example, is working on a herpes vaccine called HSV529 in partnership with the National Institute of Allergy and Infectious Diseases. The vaccine is categorised as a replication-defective virus, which means it has all of the HSV virus’s components minus two key proteins required in viral DNA replication, UL5 and UL29. GlaxoSmithKline plc started phase 1 human clinical trials for their investigational HSV-2 vaccine in March 2021, with the goal of determining the reactogenicity, safety, and immunogenicity of four different dosage levels of the vaccine in healthy adults aged 18 to 40. Furthermore, rising government support for the development of novel therapeutics for the treatment of genital herpes is expected to drive market expansion during the forecast period. Furthermore, in developed countries, accurate diagnostic techniques such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, and real-time PCR assays are widely utilized to identify STIs. These tests are effective for diagnosing asymptomatic infections, which will boost demand for genital herpes therapy and propel the industry forward. Inadequate reimbursement and a poor treatment seeking rate for genital herpes, on the other hand, will stifle market growth between 2021 and 2027. Although, throughout the forecast period, increasing demand for genital herpes treatment medicines by homosexuals presents a profitable opportunity for the market.

The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Genital Herpes Treatment market. Because of the significant growth of herpes cases in the region, North America is the world’s top region in terms of market share. According to the Centers for Disease Control and Prevention, genital herpes affects one out of every six persons in the United States between the ages of 14 and 49. Whereas, Asia-Pacific is expected to expand at the fastest pace during the forecast period, as the region’s quickly growing population, as well as increased awareness and diagnosis, would provide attractive potential opportunities for the Genital Herpes Treatment market.

Major market player included in this report are:
Teva Pharmaceutical Industries Ltd
Abbott Laboratories
Sun Pharmaceuticals Industries Ltd.
Mylan N.V.
Pfizer Inc.
GlaxoSmithKline plc
Dr. Reddy’s Laboratories ltd.
Novartis AG
Valeant Pharmaceuticals International Inc.
Genocea Biosciences
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed inRoute of Administrationation about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Acyclovir
Valacyclovir
Famciclovir
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Route of Administration:
Oral
Topical
Injectable
By Indication:
HSV-1
HSV-2

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Genital Herpes Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Genital Herpes Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Genital Herpes Treatment Market, by Drug Type, 2019-2027 (USD Billion)
1.2.3. Genital Herpes Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
1.2.4. Genital Herpes Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.5. Genital Herpes Treatment Market, by Indication, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Genital Herpes Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Genital Herpes Treatment Market Dynamics
3.1. Genital Herpes Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising frequency of sexually transmitted diseases
3.1.1.2. Expanding clinical trials of genital herpes vaccines
3.1.2. Market Challenges
3.1.2.1. Inadequate reimbursement and a poor treatment seeking rate for genital herpes
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for genital herpes treatment medicines by homosexuals
Chapter 4. Global Genital Herpes Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Genital Herpes Treatment Market, by Drug Type
5.1. Market Snapshot
5.2. Global Genital Herpes Treatment Market by Drug Type, Performance – Potential Analysis
5.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
5.4. Genital Herpes Treatment Market, Sub Segment Analysis
5.4.1. Acyclovir
5.4.2. Valacyclovir
5.4.3. Famciclovir
Chapter 6. Global Genital Herpes Treatment Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Genital Herpes Treatment Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
6.4. Genital Herpes Treatment Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Drug Stores
Chapter 7. Global Genital Herpes Treatment Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Genital Herpes Treatment Market by Route of Administration, Performance – Potential Analysis
7.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
7.4. Genital Herpes Treatment Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Topical
7.4.3. Injectable
Chapter 8. Global Genital Herpes Treatment Market, by Indication
8.1. Market Snapshot
8.2. Global Genital Herpes Treatment Market by Indication, Performance – Potential Analysis
8.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
8.4. Genital Herpes Treatment Market, Sub Segment Analysis
8.4.1. HSV-1
8.4.2. HSV-2
Chapter 9. Global Genital Herpes Treatment Market, Regional Analysis
9.1. Genital Herpes Treatment Market, Regional Market Snapshot
9.2. North America Genital Herpes Treatment Market
9.2.1. U.S. Genital Herpes Treatment Market
9.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2027
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2027
9.2.1.4. Indication breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Genital Herpes Treatment Market
9.3. Europe Genital Herpes Treatment Market Snapshot
9.3.1. U.K. Genital Herpes Treatment Market
9.3.2. Germany Genital Herpes Treatment Market
9.3.3. France Genital Herpes Treatment Market
9.3.4. Spain Genital Herpes Treatment Market
9.3.5. Italy Genital Herpes Treatment Market
9.3.6. Rest of Europe Genital Herpes Treatment Market
9.4. Asia-Pacific Genital Herpes Treatment Market Snapshot
9.4.1. China Genital Herpes Treatment Market
9.4.2. India Genital Herpes Treatment Market
9.4.3. Japan Genital Herpes Treatment Market
9.4.4. Australia Genital Herpes Treatment Market
9.4.5. South Korea Genital Herpes Treatment Market
9.4.6. Rest of Asia Pacific Genital Herpes Treatment Market
9.5. Latin America Genital Herpes Treatment Market Snapshot
9.5.1. Brazil Genital Herpes Treatment Market
9.5.2. Mexico Genital Herpes Treatment Market
9.6. Rest of The World Genital Herpes Treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Teva Pharmaceutical Industries Ltd
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Sun Pharmaceuticals Industries Ltd.
10.2.4. Mylan N.V.
10.2.5. Pfizer Inc.
10.2.6. GlaxoSmithKline plc
10.2.7. Dr. Reddy’s Laboratories ltd.
10.2.8. Novartis AG
10.2.9. Valeant Pharmaceuticals International Inc.
10.2.10. Genocea Biosciences
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now